Gemma Biotherapeutics ("GEMMABio"), a clinical‑stage, global, genetic medicines company, today announced the presentation of preclinical data supporting candidate declaration for GB703, a novel, ...
MEDICINES for babies with spinal muscular atrophy will be funded by the NHS for all patients for the first time. Little Mix ...
Hundreds more children with muscle-wasting condition spinal muscular atrophy (SMA) are to be offered potentially “life-changing” therapy on the NHS which could help them live ...
The Independent on MSN
Five early signs of SMA every parent should look out for
What is SMA? Key signs to look out for in babies as Jesy Nelson highlights life-changing condition - Pop star Jesy Nelson has ...
Key signs of spinal muscular atrophy include severe muscle weakness, difficulty breathing or swallowing, and missing ...
Spinal muscular atrophy is a rare, genetic condition that causes progressive muscle weakness and loss of movement, and can ...
A new qualitative participatory study explored how powered mobility (PM), in the form of modified ride-on cars, impacts children with spinal muscular atrophy type 1 (SMA1) and their families. Here are ...
Medicines watchdog approves two treatments for patients with spinal muscular atrophy ...
Please provide your email address to receive an email when new articles are posted on . At the time of last follow up, 82.6% of children born with SMA type 1 from 2016 on were still alive. Of the 140 ...
PHILADELPHIA--(BUSINESS WIRE)--Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 ...
—A new qualitative participatory study explored how powered mobility (PM), in the form of modified ride-on cars, impacts children with spinal muscular atrophy type 1 (SMA1) and their families. Here ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results